USPSTF2018EN
Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
Zusammenfassung
US PREVENTIVE SERVICES TASK FORCE RECOMMENDATION STATEMENT
TITLE: Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
PUBLICATION: JAMA, 2018
PMID: 29801017
RECOMMENDATION SUMMARY:
In the United States, the lifetime risk of being diagnosed with prostate cancer is approximately 13%, and the lifetime risk of dying of prostate cancer is 2.5%. The median age of death from prostate cancer is 80 years. Many men with prostate cancer never experience symptoms an
Kerninformationen
How each man weighs specific benefits and harms will determine whether the overall net benefit is small. The USPSTF concludes with moderate certainty that the potential benefits of PSA-based screening for prostate cancer in men 70 years and older do not outweigh the expected harms. For men aged 55 t...
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
USPSTF2018
USPSTF: Prostate Cancer: Screening (Grade C)
USPSTF2018
USPSTF: Prostate Cancer: Screening (Grade C, 2018)
Cancer Council Australia2026
Clinical Practice Guidelines for PSA Testing and Early Management of Test-Detected Prostate Cancer
USPSTF2021
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.
USPSTF2018
Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement.
USPSTF2024
Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement.
USPSTF2019
Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement.
USPSTF2018